USA flag logo/image

An Official Website of the United States Government

ETHYLTHIORIBOSE: A NEW ANTIFUNGAL AGENT

Award Information

Agency:
Department of Health and Human Services 		Branch:
N/A 		Award ID:
7087 		Program Year/Program:
1987 / SBIR
Agency Tracking Number:
7087 		Solicitation Year:
N/A 		Solicitation Topic Code:
N/A 		Solicitation Number:
N/A
Small Business Information
Epitope Inc.
15425-e Sw Koll Parkway Beaverton, OR 97006
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1987
Title: ETHYLTHIORIBOSE: A NEW ANTIFUNGAL AGENT
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE INCIDENCE OF FUNGAL INFECTIONS HAS INCREASED MARKEDLY SINCE THE ADVENT OF BROAD-SPECTRUM ANTIBIOTICS, CORTICOSTEROIDS, CANCER CHEMOTHERAPY, AND ORGAN TRANSPLANTATION. CURRENTLY AVAILABLE ANTIFUNGAL AGENTS SUCH AS AMPHOTERICIN B ARE OFTEN AVOIDED CLINICALLY BECAUSE OF THEIR SEVERE TOXIC SIDE EFFECTS (E.G., NEPHROTOXICITY). EPITOPE, INC. HAS SYNTHESIZED ETHYLTHIORIBOSE (ETR), A WATER-SOLUBLE, ACID-STABLE ANALOG OF THE NATURALLY OCCURRING COMPOUND METHYLTHIORIBOSE. IN PRELIMINARY EXPERIMENTS, ETR HAS BEEN FOUND TO: (1) BE CYTOCIDAL TO CANDIDA ALBICANS IN VITRO, (2) HAVE NO EFFECT ON THE GROWTH OF MAMMALIAN CELLS IN VITRO, AND (3) HAVE NO APPARENT ADVERSE EFFECTS ON MICE WHEN ADMINISTERED INTRAPERITONEALLY OR INTRAVENOUSLY. THE LONG-TERM OBJECTIVE IS TO DEVELOP EFFECTIVE AND NONTOXIC ANTIFUNGAL/ANTIMICROBIAL AGENTS. THE SPECIFIC AIMSOF THIS PHASE OF THE PROJECT ARE TO: (1) DETERMINE THE IN VIVO EFFICACY OF ETR IN A MOUSE MODEL OF SYSTEMIC CANDIDIASIS, (2) DETERMINE THE TOXICITY OF ETR IN MICE, AND (3) DETERMINE THE ANTIMICROBIAL SPECTRUM OF ETR AGAINST A WIDE VARIETY OF CLINICAL ISOLATES. THE DEVELOPMENT OF A NONTOXIC ANTIFUNGAL AGENT WILL ALLOW EARLY THERAPEUTIC INTERVENTION IN PATIENTS WITH SUSPECTED FUNGAL INFECTIONS AS WELL AS PROPHYLACTIC TREATMENT IN IMMUNOCOMPROMISED PATIENTS.

Principal Investigator:

Adolph j ferro phd
5036416115

Business Contact:

Small Business Information at Submission:

Epitope Inc
15425-e Southwest Koll Parkway Beaverton, OR 97006

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No